According to a new report from Intel Market Research, the global Bupropion Hydrochloride Extended-Release Tablets market was valued at USD 4,174 million in 2024 and is projected to reach USD 5,720 million by 2031, growing at a steady CAGR of 4.7% during the forecast period (2025-2031). This growth reflects the expanding use of bupropion in treating major depressive disorders and smoking cessation, coupled with increasing mental health awareness worldwide.
Read MoreAccording to a new report from Intel Market Research, the global Etonogestrel market was valued at USD 852 million in 2024 and is projected to reach USD 1,128 million by 2031, growing at a CAGR of 4.2% during the forecast period (2025-2031). This steady growth is driven by rising demand for hormonal contraceptives, increasing awareness about family planning, and expanding applications in gynecological treatments.
Read MoreAccording to a new report from Intel Market Research, the global Gene Expression Assay Service market was valued at USD 555 million in 2024 and is projected to reach USD 810 million by 2031, growing at a steady CAGR of 5.6% during the forecast period (2024–2031). This growth trajectory stems from escalating demand for precision medicine, advancements in genomics research, and the increasing need for biomarker discovery across therapeutic areas.
Read MoreAccording to a new report from Intel Market Research, the global ATP Consumables for Healthcare market was valued at USD 336 million in 2024 and is projected to reach USD 607 million by 2031, growing at a CAGR of 9.3% during the forecast period (2025–2031). This growth is driven by increasing emphasis on hospital infection control, stringent hygiene regulations, and the rising adoption of rapid microbial detection methods.
Read MoreAccording to a new report from Intel Market Research, the global Fractional Flow Reserve Derived from CT (FFRCT) Analysis Software market was valued at USD 65.9 million in 2024 and is projected to reach USD 137 million by 2031, growing at a strong CAGR of 11.4% during the forecast period (2024-2031). This growth is driven by increasing adoption of non-invasive cardiac diagnostics, rising prevalence of coronary artery disease, and technological advancements in AI-powered medical imaging.
Read More